Immunotherapeutic Strategies in Chronic Lymphocytic Leukemia: Advances and Challenges

Overview of attention for article published in Frontiers in oncology, February 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news: 3 news outlets

twitter: 7 X users

Readers on

mendeley: 23 Mendeley

So far, Altmetric has seen 3 news stories from 3 outlets.

'Promising' New Txs for Most Common Adult Leukemia

Medscape, 11 Sep 2023

The rapid rise of chimeric antigen receptor T (CAR T-cell) therapy has allowed hematologists to make great strides in treating…

‘Promising’ new txs for most common adult leukemia

Pediatric News , 08 Sep 2023

The rapid rise of chimeric antigen receptor T (CAR T-cell) therapy has allowed hematologists to make great strides in treating…

Scientists Review New Research Strategies for Treating CLL

AJMC, 15 Mar 2022

Approaches such as new types of monoclonal antibodies and chimeric antigen receptor natural killer cells could change how…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.